FDA Inspection 614146 — ABBE Laboratories, Inc.

ABBE Laboratories, Inc. — FEI 3004433842

The FDA completed an inspection of ABBE Laboratories, Inc. on Sep 25, 2009 in Farmingdale, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 25, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)

Citations

IDCFRDescription
162621 CFR 211.130Procedures are written, and followed
191421 CFR 211.166(a)Lack of written stability program
356921 CFR 211.89Quarantine of Rejected Components et. al.
439121 CFR 211.180(e)(2)Items to cover on annual reviews

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.